20641810|t|3-<i>N</i>-[<sup>11</sup>C]Methylspiperone
20641810|a|Dopamine, a neurotransmitter, plays an important role in the mediation of movement, cognition, and emotion (1, 2). Dopamine shortage plays a role in various neuropsychiatric disorders, such as Parkinson s disease (PD), schizophrenia, autism, attention deficit hyperactivity disorder, and drug abuse. Two subtypes of dopamine receptors, D<sub>1</sub> and D<sub>2/3</sub>, were well characterized pharmacologically and biochemically (3). D<sub>2/3</sub> dopamine receptors have been implicated in the pathophysiology of PD, Alzheimer's disease, Huntington s disease (HD), and schizophrenia (4). Serotonin (5-hydroxytryptamine, 5-HT) has diverse physiological roles as a neurotransmitter in the central nervous system (5). It also is a regulator of smooth muscle function and platelet aggregation. The brain cortical 5-HT system has been implicated in several neuropsychiatric disorders, including major depression, anxiety, obsessive-compulsive disorder, and schizophrenia (6, 7). Spiperone and its analog, 3-<i>N</i>-methylspiperone (NMSP), are high-affinity D<sub>2/3</sub> dopamine and 5-HT<sub>2A</sub> serotonin receptor antagonists, showing a low affinity for a<sub>1</sub>-adrenergic receptors (8, 9). 3-<i>N</i>-[<sup>11</sup>C]Methylspiperone ([<sup>11</sup>C]NMSP) has been studied as a positron emission tomography (PET) tracer for imaging D<sub>2/3</sub> and 5HT<sub>2A</sub> receptor densities.
20641810	43	51	Dopamine	Chemical	MESH:D004298
20641810	158	166	Dopamine	Chemical	MESH:D004298
20641810	200	226	neuropsychiatric disorders	Disease	MESH:D001523
20641810	236	255	Parkinsonâs disease	Disease	MESH:D010300
20641810	257	259	PD	Disease	MESH:D004194
20641810	262	275	schizophrenia	Disease	MESH:D012559
20641810	277	283	autism	Disease	MESH:D001321
20641810	285	325	attention deficit hyperactivity disorder	Disease	MESH:D001289
20641810	331	341	drug abuse	Disease	MESH:D019966
20641810	561	563	PD	Disease	MESH:D004194
20641810	565	584	Alzheimer's disease	Disease	MESH:D000544
20641810	586	606	Huntingtonâs disease	Disease	MESH:D006816
20641810	608	610	HD	Disease	MESH:D004194
20641810	617	630	schizophrenia	Disease	MESH:D012559
20641810	636	645	Serotonin	Chemical	MESH:D012701
20641810	647	666	5-hydroxytryptamine	Chemical	MESH:D012701
20641810	668	672	5-HT	Chemical	MESH:D012701
20641810	816	836	platelet aggregation	Disease	MESH:D001791
20641810	857	861	5-HT	Chemical	MESH:D012701
20641810	900	926	neuropsychiatric disorders	Disease	MESH:D001523
20641810	938	954	major depression	Disease	MESH:D003865
20641810	956	963	anxiety	Disease	MESH:D001007
20641810	965	994	obsessive-compulsive disorder	Disease	MESH:D009771
20641810	1000	1013	schizophrenia	Disease	MESH:D012559
20641810	1022	1031	Spiperone	Chemical	MESH:D013134
20641810	1048	1074	3-<i>N</i>-methylspiperone	Chemical	-
20641810	1076	1080	NMSP	Chemical	-
20641810	1117	1125	dopamine	Chemical	MESH:D004298
20641810	1130	1134	5-HT	Chemical	MESH:D012701
20641810	1310	1314	NMSP	Chemical	-
20641810	Association	MESH:D012701	MESH:D001523
20641810	Association	MESH:D004298	MESH:D001321
20641810	Negative_Correlation	MESH:D012701	MESH:D013134
20641810	Association	MESH:D004298	MESH:D001523
20641810	Association	MESH:D004298	MESH:D010300
20641810	Association	MESH:D004298	MESH:D012559
20641810	Association	MESH:D012701	MESH:D003865
20641810	Association	MESH:D004298	MESH:D001289
20641810	Association	MESH:D004298	MESH:D000544
20641810	Positive_Correlation	MESH:D012701	MESH:D001791
20641810	Association	MESH:D012701	MESH:D009771
20641810	Association	MESH:D012701	MESH:D001007
20641810	Association	MESH:D012701	MESH:D012559
20641810	Association	MESH:D004298	MESH:D019966
20641810	Association	MESH:D004298	MESH:D013134
20641810	Association	MESH:D004298	MESH:D004194
20641810	Association	MESH:D004298	MESH:D006816

